โš™

Pathophysiology Nodes

4
4 shared nodes are defined in this module.
โ—‰

Cell Types

1
corticotroph CL:0002309
โ‡„

Biological Processes

4
protein deubiquitination GO:0016579 INCREASED EGFR signaling GO:0007173 INCREASED POMC transcriptional activation GO:0045944 INCREASED corticotropin secretion GO:0051458 INCREASED
i

Notes

This module is currently anchored by USP8-mutant Cushing disease. Other corticotroph adenoma mechanisms should conform to downstream nodes only when the EGFR/POMC/ACTH biology is actually supported.
โ†—

Used By Disorder Entries

1
โฌก

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Corticotroph EGFR/POMC/ACTH Activation Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
โš™

Pathophysiology

4
Increased USP8 deubiquitinase activity
trigger
Activating USP8 mutations disrupt normal 14-3-3-dependent control and increase USP8 proteolytic cleavage and catalytic deubiquitinase activity.
corticotroph CL:0002309
protein deubiquitination GO:0016579 INCREASED
Sustained EGFR signaling in corticotrophs
central effector
Increased USP8-dependent EGFR deubiquitination impairs EGFR downregulation, sustaining EGFR signaling in corticotroph pituitary adenoma cells.
corticotroph CL:0002309
EGFR signaling GO:0007173 INCREASED
Increased POMC transcriptional activation
effector
USP8-mutant corticotroph adenoma cells show increased promoter activity of POMC, the precursor gene for ACTH.
corticotroph CL:0002309
POMC transcriptional activation GO:0045944 INCREASED
Increased corticotropin secretion
consequence
Corticotroph tumor cells secrete excess ACTH downstream of the USP8-EGFR-POMC axis, producing pituitary ACTH hypersecretion and Cushing disease physiology.
corticotroph CL:0002309
corticotropin secretion GO:0051458 INCREASED